Comparison of SOX and CAPOX in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: A randomized controlled trial

Abstract Background: Optimal adjuvant chemotherapy after laparoscopic surgery in gastric cancer (GC) patients is still undefined. We aimed to evaluate the efficacy of S‐1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (CAPOX) in patients with GC after laparoscopic gastrectomy. Methods: A n...

Full description

Bibliographic Details

Published in:	Cancer Medicine
Main Authors:	Xin Liu, Yongjia Yan, Li Lu, Yang Liu, Jun Ma, Xi Wang, Daohan Wang, Bang Liu, Zhuo Liu, Xueying Zhou, He Cui, Zhicheng Zhao, Chuan Li, Jian Liu, Weidong Li, Qing‐Xing Huang, Qun Zhao, Tong Liu, Weihua Fu
Format:	Article
Language:	English
Published:	Wiley 2024-06-01
Subjects:	chemotherapy gastric cancer surgery survival
Online Access:	https://doi.org/10.1002/cam4.7326